Journal
Frontiers in Health Services
Publication Date
1-1-2022
Volume
2
First Page
1024541
Document Type
Open Access Publication
DOI
10.3389/frhs.2022.1024541
Rights and Permissions
Hankins JS, Potter MB, Fernandez ME, Melvin C, DiMartino L, Jacobs SR, Bosworth HB, King AA, Simon J, Glassberg JA, Kutlar A, Gordeuk VR, Shah N, Baumann AA and Klesges LM and the Sickle Cell Disease Implementation Consortium (2023) Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease. Front.Health Serv. 2:1024541. doi: 10.3389/frhs.2022.1024541 © 2023 Hankins, Potter, Fernandez, Melvin, DiMartino, Jacobs, Bosworth, King, Simon, Glassberg, Kutlar, Gordeuk, Shah, Baumann, Klesges and the Sickle Cell Disease Implementation Consortium. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Hankins, J S; King, A A; Baumann, A A; Klesges, L M.; and et al., "Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease." Frontiers in Health Services. 2, 1024541 (2022).
https://digitalcommons.wustl.edu/oa_4/3860
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
